Onipa, James Khalid B.

HRN: 23-46-16  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/30/2023
CEFUROXIME 750MG (VIAL)
07/30/2023
08/06/2023
IV
250mg
Q24h
Pcap C
Checking Final Appropriateness 
07/30/2023
CEFUROXIME 750MG (VIAL)
07/30/2023
08/06/2023
IV
250mg
Q8h
Pcap C
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: